RPAM
STML
Rhenman & Partners Asset Management’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-650,000
| Closed | -$3.15M | – | 99 |
|
|
2020
Q1 | $3.15M | Sell |
650,000
-110,181
| -14% | -$533K | 0.44% | 64 |
|
|
2019
Q4 | $8.08M | Buy |
760,181
+249,158
| +49% | +$2.65M | 0.89% | 48 |
|
|
2019
Q3 | $5.32M | Buy |
511,023
+17,024
| +3% | +$177K | 0.67% | 55 |
|
|
2019
Q2 | $7.57M | Buy |
+493,999
| New | +$7.57M | 0.83% | 49 |
|